“…A clinical isolate of Escherichia coli (isolate 515; generously provided by D. Centron, IMPaM, UBA-CONICET, Buenos Aires, Argentina) and Pseudomonas aeruginosa PAO-1 (31) were grown in Luria-Bertani agar (Britania, Buenos Aires, Argentina) and were suspended in RPMI 1640 medium (Life Technologies, Grand Island, NY) at a concentration of 1 ϫ 10 9 CFU/ml. Lactococcus lactis MG1363 carrying the pKS80 vector containing full-length spa or an empty-vector control (provided by Tim Foster, Trinity College, Dublin, Ireland) was grown in M17 medium supplemented with 0.5% glucose and 5 g/ml erythromycin at 30°C without agitation (29,32,33). Cells were harvested by centrifugation at 10,000 rpm for 10 min, and the pellet was suspended in RPMI 1640 medium (Life Technologies, Grand Island, NY) at a concentration of 5 ϫ 10 8 CFU/ml.…”